FDA Approved: TRI-LEGEST FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TRI-LEGEST FE 28 DAY, a combined oral contraceptive containing norethindrone acetate and ethinyl estradiol, by Teva …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• TRI-LEGEST FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for TRI-LEGEST FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)